Table 3.
ORs (95%CI) for NAFLD in type 2 diabetes according to SVR tertiles
| Univariate | Model1 | Model2 | ||||
|---|---|---|---|---|---|---|
| OR | P | OR | P | OR | P | |
| Men | ||||||
| Q1 | 4.27(2.12–8.61) | 0.000 | 4.79(2.17–10.56) | 0.000 | 2.83(0.55–8.43) | 0.213 |
| Q2 | 2.26(1.12–4.55) | 0.022 | 2.38(1.16–4.88) | 0.018 | 1.43(0.40–5.17) | 0.581 |
| Q3 | 1(reference) | – | 1 | – | 1 | – |
| women | ||||||
| Q1 | 3.43(1.70–6.91) | 0.001 | 4.41(1.99–9.74) | 0.001 | 3.43(1.41–8.74) | 0.020 |
| Q2 | 1.98(0.98–3.97) | 0.056 | 2.41(1.13–5.13) | 0.023 | 2.31(1.01–5.63) | 0.046 |
| Q3 | 1 | – | 1 | – | 1 | – |
Model1: adjusted for age
Model2: further adjusted for duration diabetes, BMI, waist, SBP, DBP, HbA1c, smoker, alcohol, ALT, AST, TC, TG, HDL-C, LDL-C, and medication history for diabetes and dyslipidemia